OOIR: Observatory of International Research

Papers

(The TQCC of Blood Coagulation & Fibrinolysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Multiple thrombotic sources and embolic events at arterial sites in a patient with protein-C deficiency	64
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms	18
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding	17
New treatments for primary immune thrombocytopenia	17
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	13
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	13
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing	11
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe	11
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis	10
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment	9
Clot waveform analysis in hemophilia carriers	9
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays	9
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene	9
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans	9
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency	8
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	8
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes	7
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin	7
The physiology of hemostasis	7
Obesity and physical exercise in hemophilia	7
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis	7
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	7
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome	7
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays	7
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients	6

Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab	6
Clinical characteristics and outcomes of patients with isolated pulmonary embolism	6
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease	6
Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States	6
Disability and the social impact of hemophilia	6
The procoagulant potential before and after surgery for endometriosis and its association with disease severity	6
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report	5
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants	5
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus	5
Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study	5
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis	5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population	5
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy	5
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury	5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India	5
Acquired Bernard–Soulier syndrome and hypodysfibrinogenaemia because of multiple myeloma	5
Evaluation of the activated partial thromboplastin time and its influential factors in ischemic heart disease patients under heparin treatment	4
Harmonizing factor assay-related testing performed in a large laboratory network	4
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests	4
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism	4
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	4
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians	4
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?	4
Why do patients with antiphospholipid syndrome bleed? A clinical paradox	4
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency	4
Optimizing factor VIII dosing in obese individuals with haemophilia A	4
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study	4
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics	4
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency	4
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations	3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment	3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient	3
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations	3
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	3
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases	3
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays	3
A rare case of essential thrombocythemia with pseudo-hyperkalemia	3
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays	3
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening	3
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience	3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B	3
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies	3
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities	3
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage	3
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding	3
Interpreting coagulation mixing study results in the era of direct oral anticoagulants	3
Optimal dosing of bemiparin for deep vein thrombosis treatment in children: a retrospective study	2
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose	2
Thrombin generation assay: the present and the future	2

Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey	2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery	2
Disseminated intravascular coagulation in acute leukemia patients	2
Bleeding disorders in Saudi Arabia, causes and prevalence: a review	2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event	2
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates	2
Management of autoimmune factor XIII deficiency in a frail, elderly patient	2
Naive haemophilia mice displayed different pattern of cytokine profiles of cytokine profiles changes might be associated with subclinical bleeding	2
Hemostatic cover in orthopedic surgery	2
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII	2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism	2
Relationship between oxidant-antioxidant status and hypercoagulobility indices in children with iron deficiency anaemia	2
Sustained good response to rituximab in acquired von Willebrand syndrome	2
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease	2
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate	2
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets	2
A challenging case of heparin-induced skin necrosis without thrombocytopenia	2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review	2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency	2
Maternal thrombin generation and D-dimer levels in obesity and pregnancy: results from the maternal thrombin generation in obesity and pregnancy (MaTOPs) study	2
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience	2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major	2
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease	2
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study	2
Psychological complications among patients with congenital bleeding disorders	2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review	2
Measuring coagulopathy in pediatric craniofacial surgery	2
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial	2
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score	2
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada	2
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study	2
Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study	2